Professional Documents
Culture Documents
LABORATORY ABNORMALITIES IN
LIVER DISORDERS
By :
Dr. MONANG SIAHAAN, SpPK(K)
Dr.CORIEJATI RITA, SpPK, MM
RES
Bilirubin metabolism:
80 % mature RBC
20 % immature RBC, other heme
Hemoglobin
heme + globin
Heme
Biliverdin + Co + Fe ++
Bilirubin
CIRCULA
-TION
1
2
3
4
5
6
Bilirubin Mesobilirubinogen
Urobilinogen
Urobilinogen
Stercobilinogen
Urobilinogen urine
Faeces stercobilinogen
Urobilin
Stercobilin
DIFFERENCES BETWEEN
DIRECT & INDIRECT BILIRUBIN
DIRECT BILIRUBIN
* POST HEPATIC
INDIRECT BILIRUBIN
* PREHEPATIC
* CONJUGATED
* UNCONJUGATED
* POLAR
* NON POLAR
* DISSOLVED IN WATER
* NON DISSOLVED
* POSITIVE IN URINE
* NEGATIVE
* MONO / DIGLUCURONIDE
* PURE BILIRUBIN
1. BILIRUBIN IN SERUM
Method :
MALLOY - EVELYN
Principle
Bilirubin + diazo reagent
azobilirubin (red)
Normal value in serum < 1 mg%
increased total bilirubin find in :
a. Overproduction
b. Hepatocellular dysfunction
c. Obstruction of bile duct
2. UROBILINOGEN/UROBILIN
Method :
Urobilinogen
Urobilin
Normal :
Morning urine (-)
Day urine (+)
Wallace Diamond
Schlessinger
DECREASE UROBILINOGEN
* Bilirubin enter intestine
* Renal dysfunction
* Urobilinogen production disturbance
INCREASE UROBILINOGEN
* Liver dysfunction
* Bilirubin overproduction
3. STERCOBILINOGEN / STERCOBILIN
Dark stool
stercobilinogen
stercobilinogen
4. ICTERUS INDEX :
Determination of serum / plasma color as a quantitative
bilirubin concentration
Normal 4-6 U
5. Bromsulphthalein (BSP) test
- Uncolored substance in acid solution
-Colored within alkaline solution
Normal : after 30
retention 0 10%
after 45
retention < 3%
Abnormal : after 45
retention > 5 %
Post hepatic
Hepatic
Prehepatic
Hepatic
(bilirubin
(disturbances
Extrahepatal
overproduction) of conjugation
obstruction
& uptake)
Cholestatic intrahepata
Hepatocellular
urobilinogen (stercobilinogen)
in stool
Unconjugated Hepatichyperbilirubinemia
Pathophysiology :
Uptake & conjugation disturbance
Serum indirect bilirubin
Direct bilirubin
Urine / faeces urobilinogen
Example :
- Gilbert syndrome
- Crigler- Najjar syndrome
Laboratory :
- Icterus with indirect bilirubin
- Decrease urobilinogen
- Decrease stercobilinogen
- Urine bilirubin (-)
urobilinogen (-)
bile duct pressure
leakage bilirubin into
Laboratories :
Total
Partial
b. Faeces urobilinogen
c. Urine urobilinogen
d. Urine bilirubin
hepatitis virus
cirrhosis hepatis
Pathophysiology :
Inflammation
liver cell oedem
Liver cell necrosis
pressed cholangioles
increased permeability
: Bilirubin, Na-Benzoat
: Barbiturat, morphin
: ADH, sex-hormone, corticoteroid
ALKALINE PHOSPHATASE
Produced by bone, liver, bile duct, ect.
ALP
I. Pathologic
1. Bone disease : Paget disease, osteosarcoma
2. Liver disease :
in cholangiohepatitis. Cholestasis stimula
the synthesis of ALP in the liver
3. Non liver / bone disease : Inflammatory bowel disease,
hyperthyroidism, pancreatitis, mononucleosis infectiosa
II. Physiologic
In growing children and 3rd trimester pregnancy
ALP
in hipophosphatemia
Obstructive jaundice =
Total obstruction =
Partial
=
3-8 X
1-8 X
Hepatocellular jaundice =
1-3X
Isoenzyme of ALP placental is most heat stable
5. NUCLEOTIDASE
* Alkali phosphatase acts only on nucleoside 5"-phosphate, to
form adenosine and release inorganic phosphate
* Tissues of the body, secreted by the liver
Highest value :
* Post hepatic jaundice (obstructive jaundice)
* Intrahepatal cholestasis
: 0,07 - 16,7 /l
O
+
: 1,27 - 14,83 /l
O
+
ASPARTATE AMINOTRANSFERASE(AST/GOT)
* Catalyze the inter conversions of AA and -oxoacids by
transfer amino groups
* Cardiac muscular, liver, kidney, pancreas decrease
Reference Value :
O
: 11 - 26 U/L
O
: 10 - 20 U/L
Elevated levels in : * Hepatocellular disseases (hepatitis)
10 - 200 x normal
+
* Obstructive Hep
* Cirrhosis
<10 X Normal
* Olcoholic liver
This enzyme increase in leucemia,lymphoma,infark miocardial,
renal necrosis,mononucleosis infection
(40X)
Obstructive
(slight)
Cirrhosis
:
Myocardial infraction = N
(slight)
by
LDH1
LDH2
* Liver &
skeletal muscle
LDH4
LDH5
CHOLINESTERASE
hydrolyzes acetylcholine
choline + acetic acid
changes in liver diseases :
Parenchymatous :
Obstructive
: N
Enzyme
Source
Acethylc RBC
holine
esterase
Choline
esterase
Serum/p
lasma
PROTEIN METABOLISM
Sintezis :
albumine
fibrinogen
(alpha) & B glob
in liver
GLOBULIN
Elevated levels in liver diseases
immune response in active chronic hepatitis
& active macromodular cirrhosis
& globulin
Biliary cirrhossis
Posthepatic Jaundice
Alpha & Beta Glob
Electrophoresis
Alpha 1 globulin
: mucoprotein
glicoprotein
acute disease with fetoris, cancer
Alpha 2 & Beta Glob : lipoprotein
(alpha) glob
: antibody
Chronic disease
Acute Hepatitis
Albumin & globulin : Normal
* If alb < 3 gr/dL without increase wide damage
* If globulin > 3,5 gr/dL without decrease
* If globulin
& albumine
Cirrhosis :
- compensated
- decompensated
:N
: alb
glob
Obstructive Jaundice
:
new
: Normal
old
: albumin
globulin
cirrhosin
convalescense
FIBRINOGEN
is sintezised in liver, may be in RES
Function : blood clotting process
Determination : quantitative
semi quantitative
qualitative
Normal : 250 - 400 mg/dL
Decrease in : severe liver disease ( acute hepatic necrosis )
Prothrombin
is synthesized in liver
Decrease :
1. Poor Vitamin K in diet
2. Vitamin K absorption is lack
3. Liver cannot synthesized proth.
Obstructive jaundice : prothrombin can be normalized by
parenteral vit. K.
Parenchymatous jaundice : prothr cannot be normalized by
parenteral vit. K
Prothrombin occurred in severe liver disease ( end stage )
very bad prognose
Prothrombin Time ( PTT ) : 10 - 14 sec.
SPECIFIC PROTEIN
A. Haptoglobin :
- glyco protein
- concentration is expressed as Hemoglobin or
methemoglobin binding capacity
Normal : 100 - 200 mg/dl Hb binding capacity
Increase : post hepatic jaundice
Decrease : hepato - cellular disease
B. Lipoprotein-X (Lp-X)
* in cholestatic jaundice & Lecithin Cholesterol acyl transferase
deficiency
* Sensitive determinant for cholestatic (if there is no LCAT
deficiency) but cannot differentiate intra / extra hepatal
cholestatic
Colon cancer
Lung cancer
On protein electrophoresis move as fast as alpha 1 globulin
Not for liver function test, but for tumor marker
( monitoring therapy of carcinoma )
On non-neoplastic liver disease :
* Chronic active hepatitis
* alcoholic cirrhosis
* regenerative activy of hepatocyte
D. Ceruloplasmin
* Copper oxidase
* Normal : 34 mg/dl
* Decrease : - Wilson's disease
- Protein Energy Malnutrition
- Nephrosis
* Increase :
ACUTE HEPATITIS
I. Preicterus stadium
Symptom : fever, anorexia, malaise, abdominal discomfort
Laboratories : Abnormal BSP
Positive CCFT
AST & ALT
Urine urobilinogen : positive
others : normal
II. Icterus Stadium :
Symptom : Icteric, liver tender, afebril
Laboratories : Abnormal liver function tests
on preicteric stage
N on icteric stage
if icteric begin to disappear
N on convalescence stage
CHRONIC HEPATITIS
Chronic inflamation > 6 month
Classification :
1. Chronic persistent hepatitis
2. Chronic lobular hepatitis
3. Chronic active hepatitis
1. Chronic persistent hepatitis
Etiology : Hepatitis B virus
Hepatitis Non A Non B virus
Alcoholism
Unknown
Lab. : Normal serum bilirubin or mildly elevated serum
IgG
HEPATIC CIRRHOSIS
Is a diffuse process with fibrosis and nodule formation. It has
followed hepato-cellular necrosis. Although the causes are
many, the end result is the same
Etiology :
- Hepatitis B, non A - non B virus
- Alcoholism
- Metabolic : hemochromatosis
diabetes mellitus
Wilson's disease
- Prolonged intra & extrahepatal cholestatis
- Abnormal immunity
- Toxin & therapeutic agent
Laboratory : Compensated
transminases
GGT
urine urobilinogen
Decompensated :
Urine :
urobilinogen
(+) bilirubin
sodium in ascites
Blood :
bilirubin
albumin
gamma globulin
transaminases
alkaline phosphatase
cholesterol ester
HAEMOCHROMATOSIS
A. PRIMARY HAEMOCHROMATOSIS
Normal Iron Metabolism :
The normal daily diet contains about 10 - 20 mg of iron of
this 1 - 1,5 mg is absorbed
depends on body stores more
being absorbed the greater the need
Fasting iron serum is 250 / dl.
The normal total body content of iron is about 4 g., of wich
3 g are present in hemoglobin, myoglobulin , catalase, etc
Storage iron comprises 0,5 g ; of this 0.3 is in the liver.
When its capacity is ezcceded, iron is deposited in other
parenchymol tissues.
Definition :
Primary Haemochromatosin is a metabolism disturbance of elevated
iron absorpstion for years.
Etiology : Genetic
Patologi : * A. fibrous tissue reaction is found where even the iron
is deposited
liver
pancreas
spleen, gaster
endocrine
intestine
heart
brain, nerve
skin
HEPATOCELLULAR FAILURE
Disfunction of liver cells can cause several manifestations :
1. Jaundice
2. Hepatic coma
3. Endocrine imbalance
- testicular atrophy
- gynecomastia
- lost of body hair
Oesterogen
in
- arterial spider
- palmar erythem
Oesterogen inactivation
6.disorderd blood coagulation
4. Fetor hepaticum
5. Ascites :